These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21798602)

  • 1. Inflammation in psychotic disorders: a population-based study.
    Suvisaari J; Loo BM; Saarni SE; Haukka J; Perälä J; Saarni SI; Viertiö S; Partti K; Lönnqvist J; Jula A
    Psychiatry Res; 2011 Sep; 189(2):305-11. PubMed ID: 21798602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.
    Hope S; Dieset I; Agartz I; Steen NE; Ueland T; Melle I; Aukrust P; Andreassen OA
    J Psychiatr Res; 2011 Dec; 45(12):1608-16. PubMed ID: 21889167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder.
    Hope S; Ueland T; Steen NE; Dieset I; Lorentzen S; Berg AO; Agartz I; Aukrust P; Andreassen OA
    Schizophr Res; 2013 Apr; 145(1-3):36-42. PubMed ID: 23403415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
    Raison CL; Lin JM; Reeves WC
    Brain Behav Immun; 2009 Mar; 23(3):327-37. PubMed ID: 19111923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.
    Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ
    Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.
    Hope S; Melle I; Aukrust P; Steen NE; Birkenaes AB; Lorentzen S; Agartz I; Ueland T; Andreassen OA
    Bipolar Disord; 2009 Nov; 11(7):726-34. PubMed ID: 19839997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue.
    Orre IJ; Murison R; Dahl AA; Ueland T; Aukrust P; Fosså SD
    Brain Behav Immun; 2009 Aug; 23(6):868-74. PubMed ID: 19362138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory evidence for the psychosis continuum model.
    Mørch RH; Dieset I; Færden A; Hope S; Aas M; Nerhus M; Gardsjord ES; Joa I; Morken G; Agartz I; Aukrust P; Djurovic S; Melle I; Ueland T; Andreassen OA
    Psychoneuroendocrinology; 2016 May; 67():189-97. PubMed ID: 26923849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory markers and physical performance among nonagenarians.
    Tiainen K; Hurme M; Hervonen A; Luukkaala T; Jylhä M
    J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):658-63. PubMed ID: 20421241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
    Peralta V; Cuesta MJ
    J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders.
    Gohar SM; Dieset I; Steen NE; Mørch RH; Iversen TS; Steen VM; Andreassen OA; Melle I
    Eur Arch Psychiatry Clin Neurosci; 2019 Oct; 269(7):795-802. PubMed ID: 29721726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups.
    Joseph J; Depp C; Martin AS; Daly RE; Glorioso DK; Palmer BW; Jeste DV
    Schizophr Res; 2015 Oct; 168(1-2):456-60. PubMed ID: 26341579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study.
    McDermott MM; Guralnik JM; Corsi A; Albay M; Macchi C; Bandinelli S; Ferrucci L
    Am Heart J; 2005 Aug; 150(2):276-81. PubMed ID: 16086930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory markers and loss of muscle mass (sarcopenia) and strength.
    Schaap LA; Pluijm SM; Deeg DJ; Visser M
    Am J Med; 2006 Jun; 119(6):526.e9-17. PubMed ID: 16750969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study.
    Mørch RH; Dieset I; Faerden A; Hope S; Aas M; Nerhus M; Gardsjord ES; Haram M; Falk RS; Joa I; Morken G; Agartz I; Aukrust P; Djurovic S; Melle I; Ueland T; Andreassen OA
    Acta Psychiatr Scand; 2017 Oct; 136(4):400-408. PubMed ID: 28815548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body composition in psychotic disorders: a general population survey.
    Saarni SE; Saarni SI; Fogelholm M; Heliövaara M; Perälä J; Suvisaari J; Lönnqvist J
    Psychol Med; 2009 May; 39(5):801-10. PubMed ID: 18713488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between depression and C-reactive protein in a screening population.
    Douglas KM; Taylor AJ; O'Malley PG
    Psychosom Med; 2004; 66(5):679-83. PubMed ID: 15385691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms.
    Stojanovic A; Martorell L; Montalvo I; Ortega L; Monseny R; Vilella E; Labad J
    Psychoneuroendocrinology; 2014 Mar; 41():23-32. PubMed ID: 24495605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.